E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/7/2016 in the Prospect News PIPE Daily.

Weatherford expands as oil drops; BioMarin jumps on takeout chatter; older Tesla thrashed

By Rebecca Melvin

New York, July 7 – Light volumes persisted in U.S. convertibles on Thursday, but a couple of important names traded notably better despite a slide in oil prices and pullback in equities throughout the session, market players said.

Weatherford International Ltd. performed well, expanding about 0.75 point on a dollar-neutral basis, as oil prices tumbled more than $2.00, or 5%, to $45.17 per barrel as oversupply fears resurfaced following soft U.S. inventory data.

BioMarin Pharmaceutical Inc.’s convertibles jumped on an outright basis and expanded on swap after a report that Swiss pharmaceutical company Roche is mulling a buyout offer for the San Rafael, Calif.-based pharmaceutical company, which makes a drug for a rare, genetic muscular dystrophy disease.

Last month the BioMarin bonds gained on rumors of buyout interest from Sanofi as a backup if the French drug company’s takeover bid for Medivation failed.

Moving in the opposite direction, Tesla Motors Inc.’s 1.5% convertibles, or the old bonds, were “trading horrible,” a sellsider said.

The Tesla bond was quoted at 2.875 points below parity on Thursday, which was down from about 1 point less than parity last week.

“Borrow is too tough to fund this trade,” the sellsider said.

A second source said, “There are different dynamics pulling [Tesla] in different ways. Given the short interest, it is one of the more difficult names to short, and there has been a lot of news out in the name.”


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.